Comprehensive molecular analysis identifies RET alterations association with response of ICIs in multi-immunotherapy cohorts

医学 肿瘤科 免疫疗法 队列 内科学 癌症 免疫系统 免疫原性 免疫学
作者
Junyu Long,Rui‐Zhe Li,Dongxu Wang,Hui Liu,Jincheng Tian,Zi‐Niu Ding,Lun‐Jie Yan,Zhao‐Ru Dong,Jian‐Guo Hong,Bao‐Wen Tian,Cheng‐Long Han,Haitao Zhao,Tao Li
出处
期刊:International Immunopharmacology [Elsevier]
卷期号:126: 111281-111281 被引量:6
标识
DOI:10.1016/j.intimp.2023.111281
摘要

The RET gene, which is frequently mutated across many types of cancer, has been proven to be critically involved in tumorigenesis and tumour development; however, its prediction of the therapeutic efficacy of immune checkpoint inhibitor (ICI) therapy remains to be elucidated. The present research aims to investigate the association between RET mutations and the efficiency of ICI therapy. We analysed the role of RET mutations in predicting the prognosis of patients receiving ICIs therapy in the discovery cohort and validated it in the validation cohort. Then, multi-omics data from TCGA pan-cancer cohort was employed to propose the association between RET mutations and tumour inflamed anti-tumour immune response and tumour antigenicity. Our study revealed that among 606 cases and across five types of cancer, RET mutation was associated with better clinical outcomes for ICIs therapy, including elevated response rate, longer progression-free survival PFS, and longer overall survival OS. Multivariate analysis showed that RET mutation could independently predict the prognosis of patients treated with ICIs, after adjusting cancer types. The predictive value of RET status for the OS of patients treated with ICIs immunotherapy was further validated in the validation cohort (n = 1,409). Subgroup analysis suggested that only the monotherapy group showed significant differences in OS(P < 0.05) and PFS(P < 0.05) between RET-wildtype tumours and RET-mutant tumours. Multi-omics data analysis revealed potential anti-tumour immunity mechanisms of RET mutations, suggesting that RET-mutant tumours have enhanced immunogenicity, higher expression of immune checkpoints and chemokines, and higher immune cell infiltration than those observed in RET-wildtype tumours; thus, potentially indicating a more favourable response to immunotherapy. RET mutation may be a predictive biomarker of enhanced response to ICIs therapy. Extensive investigation of the underlying molecular mechanisms and prospective studies are needed in the future.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
雪白的山雁完成签到,获得积分10
1秒前
啦啦啦发布了新的文献求助10
2秒前
梦话完成签到,获得积分10
2秒前
2秒前
nana发布了新的文献求助10
3秒前
顾矜应助keyanqianjin采纳,获得10
5秒前
NexusExplorer应助Yummy采纳,获得10
6秒前
SONGYEZI应助G18960采纳,获得200
7秒前
Owen应助皮皮虾采纳,获得10
7秒前
9秒前
10秒前
科研通AI6应助NGU采纳,获得10
10秒前
10秒前
浮游应助一小朵采纳,获得10
11秒前
慕青应助啦啦啦采纳,获得10
11秒前
12秒前
落后的凝梦完成签到 ,获得积分10
13秒前
笨笨酒窝发布了新的文献求助10
13秒前
13秒前
NOW发布了新的文献求助10
14秒前
FashionBoy应助蛋蛋采纳,获得10
15秒前
15秒前
hongw_liu完成签到,获得积分10
15秒前
jerry发布了新的文献求助10
16秒前
赘婿应助青青泰泰采纳,获得10
16秒前
lingzi发布了新的文献求助10
17秒前
喝水吗发布了新的文献求助10
17秒前
zhzhzh完成签到,获得积分10
18秒前
超级的金毛完成签到,获得积分10
19秒前
彭于晏应助cjg采纳,获得10
20秒前
20秒前
20秒前
xuhang完成签到,获得积分10
20秒前
汉堡包应助留胡子的白柏采纳,获得10
21秒前
lhwan完成签到 ,获得积分10
21秒前
xxfsx应助明亮夜云采纳,获得10
21秒前
科研小白发布了新的文献求助10
22秒前
zzz完成签到,获得积分10
23秒前
情怀应助奋斗的怀曼采纳,获得10
23秒前
舒心的秋荷完成签到 ,获得积分10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Treatise on Geochemistry (Third edition) 1600
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 1000
List of 1,091 Public Pension Profiles by Region 981
On the application of advanced modeling tools to the SLB analysis in NuScale. Part I: TRACE/PARCS, TRACE/PANTHER and ATHLET/DYN3D 500
L-Arginine Encapsulated Mesoporous MCM-41 Nanoparticles: A Study on In Vitro Release as Well as Kinetics 500
Virus-like particles empower RNAi for effective control of a Coleopteran pest 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5458366
求助须知:如何正确求助?哪些是违规求助? 4564435
关于积分的说明 14295002
捐赠科研通 4489318
什么是DOI,文献DOI怎么找? 2458991
邀请新用户注册赠送积分活动 1448827
关于科研通互助平台的介绍 1424446